NoelR.DasguptaMD
Cardiology • Indianapolis, INAdult Congenital Heart Disease
Assistant Professor, Medicine, Indiana University School of Medicine
Overview of Dr. Dasgupta
Dr. Noel Dasgupta is a cardiologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Indiana University Health University Hospital, Indiana University Health North Hospital, Indiana University Health West Hospital, Richard L. Roudebush Veterans Affairs Medical Center, and Eskenazi Health. She received her medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 14 years. Dr. Dasgupta accepts several types of health insurance, listed below. She is one of 53 doctors at Richard L. Roudebush Veterans Affairs Medical Center and one of 157 doctors at Indiana University Health University Hospital who specialize in Cardiology. She has more than 10 publications and over 300 citings.
Office
1801 N Senate Blvd
Ste. 4000
Indianapolis, IN 46202Fax+1 317-962-0574
Education & Training
University of Florida College of Medicine JacksonvilleFellowship, Cardiovascular Disease, 2007 - 2010
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2003 - 2006
University of Wisconsin School of Medicine & Public HealthClass of 2003
Certifications & Licensure
OR State Medical License 2006 - Present
IN State Medical License 2011 - 2025
FL State Medical License 2010 - 2014
WI State Medical License 2011 - 2013
WA State Medical License 2006 - 2008- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 50 citationsImpact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature ReviewMark H. Rozenbaum, Samuel Large, Rahul Bhambri, Michelle Stewart, Jo Whelan
Cardiology and Therapy. 2021-04-20 - 19 citationsCharacteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.Teresa Coelho, Márcia Waddington Cruz, Chi-Chao Chao, Yeşim Parman, Jonas Wixner
Neurology and Therapy. 2023-02-01 - 64 citationsSafety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy.Merrill D. Benson, Noel R. Dasgupta, Stacy M. Rissing, Jessica Smith, Harvey Feigenbaum
Amyloid. 2017-09-14
Abstracts/Posters
- [Board 531] Safety of Inotersen Treatment in Patients With Transthyretin Amyloid CardiomyopathyNoel Dasgupta, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
- [Board 513] Improved Survival of Patients With Transthyretin Amyloid Cardiomyopathy With Inotersen (TTR Specific Antisense Oligonucleotide)Noel R. Dasgupta, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPOFirst Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
